Pulmonary function tests for the assessment and monitoring of asthma in children above 3 years of age;Place des EFR dans l'évaluation et la surveillance de l'asthme chez l'enfant de plus de 3 ans

Revue des Maladies Respiratoires

Volumn 20, Issue 4, 2003, Pages 638-643

  Beydon, N ^b   De Blic, J ^a   Boucot, I ^b   Bremont F ^b   Crenesse, D ^b   David, V ^b   Delacourt, C ^b   Denjean, A ^b   Deschildre, A ^b   Donnou, M D ^b   Dubus, J C ^b   Fayon, M ^b   Labbe A ^b   Le Bourgeois, M ^b   Marguet, C ^b   Matran, R ^b   Pin, I ^b   Rance F ^b   Le Roux, P ^b   Sohier, B ^b   Scheinmann, P ^b   more..

^a Serv de Pneumol/Allergol Pediat   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

AGE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS OBSTRUCTION; CHILD; DIAGNOSTIC VALUE; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG FUNCTION TEST; PROVOCATION TEST; REVIEW; SYMPTOM; TREATMENT PLANNING;

AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; ASTHMA; CHILD, PRESCHOOL; DISEASE PROGRESSION; HUMANS; INFANT; INFANT, NEWBORN; MONITORING, PHYSIOLOGIC; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 0141781294     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351: 1225-32.
2. NIH-NHLBI/WHO workshop report: Global strategy for asthma management and prevention. NIH publication 2002; O2-3659: 68-79.
3. Blanc FX, Postel-Vinay N, Boucot I, de Blic J, Scheinmann P: Étude AIRE: analyse des données recueillies chez 753 enfants asthmatiques en Europe. Rev Mal Respir 2002; 19: 585-92.
4. Verini M, Rossi N, Dalfino T, Verrotti A, Di Gioacchino M, Chiarelli F: Lack of correlation between clinical patterns of asthma and airway obstruction. Allergy Asthma Proc 2001; 22: 297-302.
5. Bye MR, Kerstein D, Barsh E: The importance of spirometry in the assessment of childhood asthma. Am J Dis Child 1992; 146: 977-8.
6. Baker RR, Mishoe SC, Zaitoun FH, Arant CB, Lucas J, Rupp NT: Poor perception of airway obstruction in children with asthma. J Asthma 2000; 37: 613-24.
7. Bahceciler NN, Barlan IB, Nuhoglu Y, Basaran MM: Risk factors for the persistence of respiratory symptoms in childhood asthma. Ann Allergy Asthma Immunol 2001; 86: 449-55.
8. Fuhlbrigge AL, Kitch BT, Paltiel AD, Kuntz KM, Neumann PJ, Dockery DW, Weiss ST: FEV(1) is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 2001; 107: 61-7.
9. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR: Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. J Allergy Clin Immunol 2002; 110: 220-7.
10. Phelan PD, Robertson CF, Olinsky A: The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol 2002; 109: 189-94.
11. Roorda RJ, Gerritsen J, van Aalderen WM, Schouten JP, Veltman JC, Weiss ST, Knol K: Follow-up of asthma from childhood to adulthood influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol 1994; 93: 575-84.
12. Grol MH, Gerritsen J, Vonk JM, Schouten JP, Koeter GH, Rijcken B, Postma DS: Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med 1999; 160: 1830-7.
13. Strachan DP, Griffiths JM, Johnston ID, Anderson HR: Ventilatory function in British adults after asthma or wheezing illness at ages 0-35. Am J Respir Crit Care Med 1996; 154: 1629-35.
14. Agertoft L, Pedersen S: Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-81.
15. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 159: 1043-51.
16. American Thoracic Society: Guidelines for Methacholine and Exercise Challenge Testing 1999. Am J Respir Crit Care Med 2000; 161: 309-29.
17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
18. Kanner RE, Schenker MB, Munoz A, Speizer FE: Spirometry in children. Methodology for obtaining optimal results for clinical and epidemiologic studies. Am Rev Respir Dis 1983; 127: 720-4.
19. Siret D, Paruit C, David V, Louvet S: Intérêt des épreuves fonctionnelles respiratoires systématiques dans l'évaluation de l'asthme chez l'enfant de trios à cinq ans. Arch Pediatr 2002; 9: 478-88.
20. Crenesse D, Berlioz M, Bourrier T, Albertini M: Spirometry in children aged 3 to 5 years: reliability of forced expiratory maneuvers. Pediatr Pulmonol 2001; 32: 56-61.
21. Crapo RO: Pulmonary-function testing. N Engl J Med 1994; 331: 25-30.
22. American Thoracic Society: Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995; 152: 1107-36.
23. Waalkens HJ, Merkus PJ, van Essen-Zandvliet EE, Brand PL, Gerritsen J, Duiverman EJ, Kerrebijn KF, Knol KK, Quanjer PH: Assessment of bronchodilator response in children with asthma. Dutch CNSLD Study Group. Eur Respir J 1993; 6: 645-51.
24. Klein RB, Fritz GK, Yeung A, McQuaid EL, Mansell A: Spirometric patterns in childhood asthma: peak flow compared with other indices. Pediatr Pulmonol 1995; 20: 372-9.
25. Konig P, Shaffer J: The effect of drug therapy on long-term outcome of childhood asthma: a possible preview of the international guidelines. J Allergy Clin Immunol 1996; 98: 1103-11.
26. Korhonen K, Korppi M, Remes ST, Reijonen TM, Remes K: Lung function in school-aged asthmatic children with inhaled cromoglycate, nedocromil and corticosteroid therapy. Eur Respir J 1999; 13: 82-6.
27. Chhabra SK: Forced vital capacity, slow vital capacity, or inspiratory vital capacity: which is the best measure of vital capacity? J Asthma 1998; 35: 361-5.
28. Merkus PJ, Mijnsbergen JY, Hop WC, de Jongste JC: Interrupter resistance in preschool children: measurement characteristics and reference values. Am J Respir Crit Care Med 2001; 163: 1350-5.
29. Quanjer PH, Stocks J, Polgar G, Wise M, Karlberg J, Borsboom G: Compilation of reference values for lung function measurements in children. Eur Respir J Suppl 1989; 4: 184S-261S.
30. Duiverman EJ, Clement J, van de Woestijne KP, Neijens HJ, van den Bergh AC, Kerrebijn KF: Forced oscillation technique. Reference values for resistance and reactance over a frequency spectrum of 2-26 Hz in healthy children aged 2.3-12.5 years. Bull Eur Physiopathol Respir 1985; 21: 171-8.
31. Mazurek H, Willim G, Marchal F, Haluszka J, Tomalak W: Input respiratory impedance measured by head generator in preschool children. Pediatr Pulmonol 2000; 30: 47-55.
32. Hordvik NL, Konig P, Morris DA, Kreutz C, Pimmel RL: Normal values for forced oscillatory respiratory resistance in children. Pediatr Pulmonol 1985; 1: 145-8.
33. Hantos Z, Daroczy B, Gyurkovits K: Total respiratory impedance in healthy children. Pediatr Pulmonol 1985; 1: 91-8.
34. Solymar L, Aronsson PH, Bake B, Bjure J: Respiratory resistance and impedance magnitude in healthy children aged 2-18 years. Pediatr Pulmonol 1985; 1: 134-40.
35. Beydon N, Amsallem F, Bellet M, Boule M, Chaussain M, Denjean A, Matran R, Wuyam B, Alberti C, Gaultier C: Pre/postbronchodilator interrupter resistance values in healthy young children. Am J Respir Crit Care Med 2002; 165: 1388-94.
36. Delacourt C, Lorino H, Herve-Guillot M, Reinert P, Harf A, Housset B: Use of the forced oscillation technique to assess airway obstruction and reversibility in children. Am J Respir Crit Care Med 2000; 161: 73O-6.
37. Delacourt C, Lorino H, Fuhrman C, Herve-Guillot M, Reinert P, Harf A, Housset B: Comparison of the forced oscillation technique and the interrupter technique for assessing airway obstruction and its reversibility in children. Am J Respir Crit Care Med 2001; 164: 965-72.
38. Nielsen KG, Bisgaard H: Discriminative capacity of bronchodilator response measured with three different lung function techniques in asthmatic and healthy children aged 2 to 5 years. Am J Respir Crit Care Med 2001; 164: 554-9.
39. Anthonisen NR, Wright EC: Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 814-9.
40. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ: Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 309-29.
41. Eid N, Yandell B, Howell L, Eddy M, Sheikh S: Can peak expiratory flow predict airflow obstruction in children with asthma? Pediatrics 2000; 105: 354-8.
42. Haby MM, Peat JK, Mellis CM, Anderson SD, Woolcock AJ: An exercise challenge for epidemiological studies of childhood asthma: validity and repeatability. Eur Respir J 1995; 8: 729-36.
43. Remes ST, Pekkanen J, Remes K, Salonen RO, Korppi M: In search of childhood asthma: questionnaire, tests of bronchial hyperresponsiveness, and clinical evaluation. Thorax 2002; 57: 120-6.
44. Jones A: Asymptomatic bronchial hyperreactivity and the development of asthma and other respiratory tract illnesses in children. Thorax 1994; 49: 757-61.
45. Rasmussen F, Taylor DR, Flannery EM, Cowan JO, Greene JM, Herbison GP, Sears MR: Outcome in adulthood of asymptomatic airway hyperresponsiveness in childhood: a longitudinal population study. Pediatr Pulmonol 2002; 34: 164-71.
46. Sears MR, Jones DT, Holdaway MD, Hewitt CJ, Flannery EM, Herbison GP, Silva PA: Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children. Thorax 1986; 41: 283-9.
47. Shingo S, Zhang J, Reiss TF: Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur Respir J 2001; 17: 220-4.
48. Kauffmann F, Dizier MH, Annesi-Maesano I, Bousquet J, Charpin D, Demenais F, Ecochard D, Feingold J, Gormand F, Grimfeld A, Lathrop M, Matran R, Neukirch F, Paty E, Pin I, Pison C, Scheinmann P, Vervloet D, Lockhart A: EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)-descriptive characteristics. Clin Exp Allergy 1999; 29: 17-21.
49. Program: NAEap. Expert panel report: guidelines for the diagnosis and management of asthma. Update on selected topics. J Allergy Clin Immunol 2002; 110: S141-S219.
50. Gern JE, Eggleston PA, Schuberth KC, Eney ND, Goldstein EO, Weiss ME, Adkinson NF, Jr: Peak flow variation in childhood asthma: a three-year analysis. J Allergy Clin Immunol 1994; 93: 706-16.
51. Sly PD, Cahill P, Willet K, Burton P: Accuracy of mini peak flow meters in indicating changes in lung function in chilren with asthma. Bmj 1994; 308: 572-4.
52. Warner JO, Naspitz CK: Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group. Pediatr Pulmonol 1998; 25: 1-17.
53. Eigen H, Bieler H, Grant D, Christoph K, Terrill D, Heilman DK, Ambrosius WT, Tepper RS: Spirometric pulmonary function in healthy preschool children. Am J Respir Crit Care Med 2001; 163: 619-23.
54. Stocks J, Quanjer PH: Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. Eur Respir J 1995; 8: 492-506.